These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2587944)

  • 21. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
    Cryz SJ; Fürer E; Germanier R
    Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a.
    Forrest BD; LaBrooy JT; Dearlove CE; Shearman DJ
    Infect Immun; 1992 Feb; 60(2):465-71. PubMed ID: 1730477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The serum polymeric IgA antibody response to typhoid vaccination; its relationship to the intestinal IgA response.
    Bartholomeusz RC; Forrest BD; Labrooy JT; Ey PL; Pyle D; Shearman DJ; Rowley D
    Immunology; 1990 Feb; 69(2):190-4. PubMed ID: 2307480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal secretory antibody response induced by an oral cholera vaccine in human volunteers.
    Langevin-Perriat A; Lafont S; Vincent C; Revillard JP; Mazert MC; Gerfaux G; Tron F
    Vaccine; 1988 Dec; 6(6):509-12. PubMed ID: 3245293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy.
    Roodnat JI; de Fijter JW; van Kooten C; Daha MR; van Es LA
    Nephrol Dial Transplant; 1999 Feb; 14(2):353-9. PubMed ID: 10069188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human humoral immune response to Salmonella typhi Ty21a.
    Forrest BD; LaBrooy JT; Beyer L; Dearlove CE; Shearman DJ
    J Infect Dis; 1991 Feb; 163(2):336-45. PubMed ID: 1988518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal immunity: implications for vaccine development.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
    Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN
    J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
    Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
    J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
    Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
    [No Abstract]   [Full Text] [Related]  

  • 33. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
    Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
    J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.
    Simanjuntak CH; Paleologo FP; Punjabi NH; Darmowigoto R; Soeprawoto ; Totosudirjo H; Haryanto P; Suprijanto E; Witham ND; Hoffman SL
    Lancet; 1991 Oct; 338(8774):1055-9. PubMed ID: 1681365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antibody response to an oral Ty21a-based typhoid-cholera hybrid is unaffected by prior oral vaccination with Ty21a.
    Dearlove CE; Forrest BD; van den Bosch L; La Brooy JT
    J Infect Dis; 1992 Jan; 165(1):182-3. PubMed ID: 1727891
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Behring Inst Mitt; 1984 Nov; (76):98-105. PubMed ID: 6395852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of vaccination against cholera and typhoid fever.
    Germanier R
    Monogr Allergy; 1975; 9():217-30. PubMed ID: 1090807
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal.
    Schwartz E; Shlim DR; Eaton M; Jenks N; Houston R
    Arch Intern Med; 1990 Feb; 150(2):349-51. PubMed ID: 2105702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum and Intestinal Antitoxin Antibody Responses after Immunization with the Whole-Cell/Recombinant B Subunit (WC/rBS) Oral Cholera Vaccine in North American and Mexican Volunteers.
    Scerpella EG; Mathewson JJ; DuPont HL; Martinez-Sandoval FG; Taylor DN; Ericsson CD
    J Travel Med; 1996 Sep; 3(3):143-147. PubMed ID: 9815442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.